Atossa Therapeutics (ATOS) Shares Issued (2022 - 2026)
Atossa Therapeutics (ATOS) posted quarterly Shares Issued of $1.3 million for Q1 2026, down 92.77% year-over-year from $17.8 million in Q1 2025, and down 17.6% quarter-over-quarter from $1.6 million in Q4 2025.
Atossa Therapeutics (ATOS) Shares Issued (2022 - 2026) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Shares Issued for 5 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 92.77% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 92.77% YoY), while the FY2025 annual figure was $1.6 million, up 13.47% from the prior year.
- Shares Issued fell to $1.3 million in Q1 2026 per ATOS's latest filing, from $1.6 million in the prior quarter.
- Across five years, Shares Issued topped out at $24.5 million in Q2 2025 and bottomed at $1.3 million in Q1 2026.
- Historically, Shares Issued has averaged $14.3 million across 5 years, with a median of $17.5 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Issued grew 25.89% — and 2026, when it slumped 92.77%.
- Atossa Therapeutics' Shares Issued stood at $13.9 million in 2022, then gained by 25.89% to $17.5 million in 2023, then tumbled by 92.12% to $1.4 million in 2024, then advanced by 13.47% to $1.6 million in 2025, then retreated by 17.6% to $1.3 million in 2026.
- Business Quant data shows ATOS's Shares Issued at $1.3 million in Q1 2026, $1.6 million in Q4 2025, and $23.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 23.49 Mn |
| Sep 30, 2025 | 23.49 Mn |
| Jun 30, 2025 | 24.51 Mn |
| Jun 30, 2025 | 24.51 Mn |
| Mar 31, 2025 | 17.85 Mn |
| Mar 31, 2025 | 17.85 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 20.20 Mn |
| Sep 30, 2024 | 20.20 Mn |
| Jun 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 20.74 Mn |
| Mar 31, 2024 | 15.32 Mn |
| Mar 31, 2024 | 15.32 Mn |